Factors influencing the spread of pertussis in households. (Q50882646)

24 March 2018

title

Factors influencing the spread of pertussis in households. (English)

1 reference

24 March 2018

author name string

C H Wirsing von König

1

1 reference

24 March 2018

S Postels-Multani

2

1 reference

24 March 2018

H Bogaerts

3

1 reference

24 March 2018

H L Bock

4

1 reference

24 March 2018

S Laukamp

5

1 reference

24 March 2018

S Kiederle

6

1 reference

24 March 2018

H J Schmitt

7

1 reference

24 March 2018

publication date

1 May 1998

1 reference

24 March 2018

European Journal of Pediatrics

published in

1 reference

24 March 2018

volume

157

1 reference

24 March 2018

issue

5

1 reference

24 March 2018

page(s)

391-394

1 reference

24 March 2018

The efficacy of pertussis vaccines under conditions of household exposure. Further analysis of the 1978-80 PHLS/ERL study in 21 area health authorities in England

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS004310050836

Use of erythromycin to prevent pertussis in newborns of mothers with pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050836

Pertussis and its prevention: a family affair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050836

Efficacy of acellular pertussis vaccine in early childhood after household exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050836

Efficacy of an acellular pertussis vaccine in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050836

Health Insurance Plan of Greater New York : A General Statement of Its Principles and Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050836

Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050836

Protection against pertussis by acellular pertussis vaccines (Takeda, Japan): household contact studies in Kawasaki City, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050836

Sensitivity and specificity of clinical case definitions for pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050836

Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050836

An Epidemiological Study of an Outbreak of Pertussis in a Public School

21 January 2018

1 reference

12 December 2020

Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled

1 reference

12 December 2020

Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany

1 reference

12 December 2020

Clinical studies on efficacy and safety of an acellular pertussis vaccine in Aichi Prefecture, Japan

1 reference

12 December 2020

Seroepidemiology of Pertussis in Italy

1 reference

12 December 2020

Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children

1 reference

12 December 2020

Erythromycin for treatment and prevention of pertussis.

1 reference

12 December 2020

Pertussis in Missouri: evaluation of nasopharyngeal culture, direct fluorescent antibody testing, and clinical case definitions in the diagnosis of pertussis.

1 reference

12 December 2020

The epidemiological situation of pertussis in the Federal Republic of Germany

1 reference

12 December 2020

Identifiers

DOI

10.1007/S004310050836

1 reference

24 March 2018

1 reference

24 March 2018